Juan Xiong

Juan Xiong

Auto-generated profile, based on publicly available information

Juan Xiong

Department of Pediatrics Clinical Research Center of Children Neurodevelopmental Disabilities of Hunan Province, Xiangya Hospital, Central South University Changsha China

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 November 2018 in Frontiers in Neurology
Verified
Journal Article
Open access
PDF file
MKMiriam Kessi
Miriam Kessi
JXJuan Xiong
Juan Xiong
LWliwen Wu
liwen Wu
LYLifen Yang
Lifen Yang
FHFang He
Fang He
JPJing Peng
Jing Peng
Introduction: The concurrence of intellectual disability/global developmental delay and epilepsy (ID/GDD-EP) is very common in the pediatric population. The etiologies for both conditions are complex and largely unknown. The predictors of significant copy number variations (CNVs) are known for the cases with ID/GDD, but unknown for those with exclusive ID/GDD-EP. Importantly, the known predictors are largely from the same ethnic group; hence, they lack replication. Purpose: We aimed to determine and investigate the diagnostic yield of CNV tests, new causative CNVs, and the independent predictors of significant CNVs in Chinese children with unexplained ID/GDD-EP. Materials and methods: A total of 100 pediatric patients with unexplained ID/GDD-EP and 1,000 healthy controls were recruited. The American College of Medical Genetics guideline was used to classify the CNVs. Additionally, clinical information was collected and compared between those with significant and non-significant CNVs. Results: Twenty-eight percent of the patients had significant CNVs, 16% had variants of unknown significance, and 56% had non-significant CNVs. In total, 31 CNVs were identified in 28% (28/100) of cases: 25 pathogenic and 6 likely pathogenic. Eighteen known syndromes were diagnosed in 17 cases. Thirteen rare CNVs (8 novel and 5 reported in literature) were identified, of which three spanned dosage-sensitive genes: 19q13.2 deletion (ATP1A3), Xp11.4-p11.3 deletion (CASK), and 6q25.3-q25.3 deletion (ARID1B). By comparing clinical features in patients with significant CNVs against those with non-significant CNVs, a statistically significant association was found between the presence of significant CNVs and speech and language delay for those aged above 2 years and for those with facial malformations, microcephaly, congenital heart disease, fair skin, eye malformations, and mega cisterna magna. Multivariate logistic regression analysis allowed the identification of two independent significant CNV predictors, which are eye malformations and facial malformations. Conclusion: Our study supports the performance of CNV tests in pediatric patients with unexplained ID/GDD-EP, as there is high diagnostic yield, which informs genetic counseling. It adds 13 rare CNVs (8 novel), which can be accountable for both conditions. Moreover, congenital eye and facial malformations are clinical markers that can aid clinicians to understand which patients can benefit from the CNV testing and which will not, thus helping patients to avoid unnecessary and expensive tests.

2 March 2022 in Clinica Chimica Acta
Verified
Journal Article
Closed access
JXJuan Xiong
Juan Xiong
SCShimeng Chen
Shimeng Chen
BCBaiyu Chen
Baiyu Chen
WZWen Zhang
Wen Zhang
CCChen Chen
Chen Chen
FYFei Yin
Fei Yin

24 January 2026 in Epilepsia
Verified
Journal Article
Closed access
JXJuan Xiong
Juan Xiong
HDHaolin Duan
Haolin Duan
JCJun Chen
Jun Chen
XYXia You
Xia You
FHFang He
Fang He
JPJing Peng
Jing Peng

1 June 2013 in Annals of the Rheumatic Diseases
Verified
Journal Article
Closed access
PDF file
SBS. J. Bartlett
S. J. Bartlett
CBC.O. Bingham
C.O. Bingham
ECE. Choy
E. Choy
JXJ. Xiong
J. Xiong
GBGilles Boire
Gilles Boire
VBV. P. Bykerk
V. P. Bykerk
Background Flares in rheumatoid arthritis (RA) are common, poorly defined, and understudied in research and clinic settings. There is an urgent need for a validated tool that can reliably and comprehensively quantify RA disease exacerbations. The OMERACT RA Flare Group is an international collaboration of researchers and clinicians working together to develop an RA flare assessment measure. The rigorous, iterative process of qualitative and quantitative research with patients and health care providers that was used to identify the core set of domains to assess in RA flares was recently ratified by OMERACT attendees. Next, we developed a single item to assess each key domain (pain, function, fatigue, participation, coping and stiffness). Here, we report results of activities to establish the convergent validity of the OMERACT preliminary flare questions (PFQ). Objectives To describe associations between responses to OMERACT PFQ items and similar questions from validated scales and indices commonly used in RA. Methods 919 participants in the Canadian early ArThritis CoHort (CATCH) completed the OMERACT PFQs at routine clinic visits from 11-2011 through 1-2013. Participants rated their pain, function, fatigue, participation, coping and stiffness over the past week using an 11-point numerical rating scale. Measures of association (Pearson, Spearman, polychoric, polyserial) were calculated between PFQ responses and relevant items/indices from the HAQ, SF12, WPAI, RADAI and other commonly used measures. Results 74% were female (74%), 83% White, and 54% completed at least high school. Mean (SD) age was 53.2 (14.7) years and RA duration of 5.9 (3.1) months. Across all, correlations were strongest between the PFQ pain rating and similar pain items from other scales (r’s=.84 to .89). Moderate-strong correlations were evident among PFQ and other items querying function (r’s= .66 to .76), fatigue (r’s= .61 to .85), participation (r’s=.64 to .78) and coping (r’s=.48 to .58). Coping ratings were weakly to moderately related to depressed mood (r=.46), anxiety (r=.33), and stress (r=.10). PFQ stiffness ratings were moderately related to early morning stiffness (r=.61). Conclusions In patients with early RA, there was substantial agreement between single item OMERACT PFQs for each domain and items from validated measures commonly used in RA research and care. These data provide evidence of convergent validity of PFQ items with other validated measures and add to the growing body of evidence supporting the validity of the OMERACT RA Flare Questionnaire. The OMERACT Flare Questionnaire is undergoing additional psychometric evaluation across a variety of RA populations and settings to establish its reliability, validity, and responsiveness prior to release for widespread use among clinicians and researchers. Disclosure of Interest S. Bartlett: None Declared, C. Bingham III: None Declared, E. Choy: None Declared, J. Xiong: None Declared, G. Boire: None Declared, B. Haraoui: None Declared, J. Pope: None Declared, J. Thorne: None Declared, C. Hitchon: None Declared, D. Tin: None Declared, E. Keystone: None Declared, V. Bykerk Grant/research support from: The CATCH study was designed and implemented by the investigators and financially supported initially by Amgen Canada Inc. and Pfizer Canada Inc. via an unrestricted research grant since inception of CATCH. As of 2011, further support was provided by Hoffmann-La Roche Ltd., United Chemicals of Belgium (UCB) Canada Inc., Bristol-Myers Squibb Canada Co., Abbvie Inc, and Janssen Biotech Inc. (a wholly owned subsidiary of Johnson & Johnson Inc.)

1 June 2013 in Annals of the Rheumatic Diseases
Verified
Journal Article
Closed access
PDF file
EKE. C. Keystone
E. C. Keystone
MOMohammed A. Omair
Mohammed A. Omair
PAP. Akhaven
P. Akhaven
ANA. Naraghi
A. Naraghi
DWD. A. Weber
D. A. Weber
MWM. L. Weber
M. L. Weber
Background Swollen joints (SJs) are a strong clinical predictor of radiographic progression in rheumatoid arthritis (RA). The metacarpal phalangeal joints (MCP) SJs are particularly relevant since they are the earliest joints demonstrating radiographic progression. Thus, more sensitive detection of less obvious SJs is important for improved assessment of disease activity. A novel four finger (FF) examination technique was developed to be more sensitive than the two finger (TF) technique in the detection of less clinically apparent joint swelling. Objectives To compare the sensitivity of the FF vs. TF technique to detect synovitis by ultrasound (US). Methods We compared the FF vs. TF examination technique in 180 MCPs in 18 RA patients. The population was comprised of 94.4% females, mean age of 55.8 yrs and mean disease duration of 19.9 yrs. Patients were examined twice on the same day by 4 rheumatologists; 2 performed FF and 2 used the TF technique. SJs were determined by palpation defined by being either (1) ballotable or (2) spongy (non-ballotable swelling). TJs were also assessed. We evaluated the agreement between the SJ/TJ examination techniques with US using grey scale, power Doppler (PD) positivity, or the presence of an effusion. Results Consistent with previous literature, the inter-observer agreement (IA) using Kappa statistics was poor to moderate for both SJ techniques. We therefore evaluated only joints in which there was agreement between the 2 examiners for each SJ technique. With the TF and FF techniques respectively, there were 115 & 134 SJs in which there were agreement for the joints being ballotable and 99 & 122 SJs for being spongy. The Kappa agreement between FF and TF techniques respectively, for ballottement by PD was 0.55 vs 0.27; by grey scale 0.35 vs. 0.12, and by effusion: 0.18 vs. 0.08. For SJ detected by being spongy, the relationship between FF and TF was the same, but the Kappas were lower. The agreement between TJs and US was extremely poor with mean Kappas for the 4 examiners for PD of 0.07; for grey scale: 0.06 and for effusion: -0.08. Conclusions The results of this study demonstrate that for MCPs, the FF technique is more sensitive than the TF technique for detection of synovitis as determined by US and therefore a better examination technique for clinical decision making. Of significance, the data provide strong support for the importance of detecting SJs (rather than TJs) as a prognostic guide for structural damage in RA. Disclosure of Interest None Declared